[go: up one dir, main page]

WO2018093238A3 - 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 - Google Patents

포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 Download PDF

Info

Publication number
WO2018093238A3
WO2018093238A3 PCT/KR2017/013297 KR2017013297W WO2018093238A3 WO 2018093238 A3 WO2018093238 A3 WO 2018093238A3 KR 2017013297 W KR2017013297 W KR 2017013297W WO 2018093238 A3 WO2018093238 A3 WO 2018093238A3
Authority
WO
WIPO (PCT)
Prior art keywords
obesity
strain
composition
active ingredient
formic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2017/013297
Other languages
English (en)
French (fr)
Other versions
WO2018093238A2 (ko
Inventor
이명기
임상동
이성훈
조용선
남영도
배진주
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Food Research Institute KFRI
Original Assignee
Korea Food Research Institute KFRI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Food Research Institute KFRI filed Critical Korea Food Research Institute KFRI
Priority to US16/462,901 priority Critical patent/US11564955B2/en
Priority to JP2019547566A priority patent/JP7012736B2/ja
Publication of WO2018093238A2 publication Critical patent/WO2018093238A2/ko
Publication of WO2018093238A3 publication Critical patent/WO2018093238A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물; 상기 유효성분을 포함하는 식품 조성물 및 건강기능식품에 관한 것이다. 본 발명에 따른 포름산 생성능이 우수한 균주는 체중 감소 및 장기의 지방 축적 억제 효과를 가질 뿐 아니라, 혈중 중성지방과 콜레스테롤의 수치를 효과적으로 낮추는 활성을 갖는바, 이를 유효성분으로 포함하는 조성물은 비만 또는 비만으로부터 야기되는 대사증후군를 예방/개선하거나 치료할 수 있는 조성물로서 유용하게 사용될 수 있다. 따라서 본 발명에 따른 포름산 생성능이 우수한 균주는 의약품 또는 건강식품 소재로서 유용하게 사용될 수 있다.
PCT/KR2017/013297 2016-11-21 2017-11-21 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 Ceased WO2018093238A2 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US16/462,901 US11564955B2 (en) 2016-11-21 2017-11-21 Composition including, as active ingredient, strain having ability to produce formic acid for preventing or treating obesity or metabolic syndromes caused by obesity
JP2019547566A JP7012736B2 (ja) 2016-11-21 2017-11-21 ギ酸生成能に優れた菌株を有効成分として含む肥満または肥満によって惹起された代謝症候群の予防または治療用組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2016-0154978 2016-11-21
KR1020160154978A KR101912774B1 (ko) 2016-11-21 2016-11-21 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물

Publications (2)

Publication Number Publication Date
WO2018093238A2 WO2018093238A2 (ko) 2018-05-24
WO2018093238A3 true WO2018093238A3 (ko) 2018-08-09

Family

ID=62145598

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/013297 Ceased WO2018093238A2 (ko) 2016-11-21 2017-11-21 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물

Country Status (4)

Country Link
US (1) US11564955B2 (ko)
JP (1) JP7012736B2 (ko)
KR (1) KR101912774B1 (ko)
WO (1) WO2018093238A2 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021080298A1 (ko) * 2019-10-24 2021-04-29 (주)닥터티제이 엔테로코커스 패칼리스를 유효성분으로 함유하는 비만 또는 비만으로부터 유도된 대사증후군의 예방 또는 치료용 조성물
JP7153274B2 (ja) * 2019-12-25 2022-10-14 京都府公立大学法人 慢性腎臓病進行抑制剤
CN114901296A (zh) * 2019-12-27 2022-08-12 国立大学法人神户大学 毛细血管疾病抑制剂、毛细血管疾病改善剂、以及毛细血管新生促进剂
KR102512802B1 (ko) 2020-04-21 2023-03-23 한국식품연구원 포름산 생성능이 우수한 엔테로코커스 패칼리스 tk1 균주, 이를 포함하는 항비만용 식품 조성물 및 이의 제조방법
CN115245523A (zh) * 2021-01-28 2022-10-28 上海市第六人民医院 青春双歧杆菌在制备脂肪吸收抑制剂中的应用
CN114042091A (zh) * 2021-10-24 2022-02-15 郑州大学 酪黄肠球菌在制备治疗代谢综合征产品中的应用方法
CN115466689B (zh) * 2022-02-09 2023-06-16 中国科学技术大学 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用
IT202200013138A1 (it) * 2022-06-22 2023-12-22 Cerbios Pharma Sa Probiotico per l’uso nel trattamento di alterazioni infiammatorie della mucosa intestinale, in particolare obesità
CN117625478A (zh) * 2023-11-29 2024-03-01 广西爱生生命科技有限公司 一种具有治疗非酒精性脂肪肝和/或减脂功能的戊糖片球菌菌株a21243及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002080357A (ja) * 2000-09-05 2002-03-19 Kao Corp 高血圧症予防・改善・治療剤
JP2002530326A (ja) * 1998-11-25 2002-09-17 ヨマー、ファルマカ、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング 感染症の治療のためのホスホノ蟻酸誘導体の使用
KR20130001744A (ko) * 2011-06-24 2013-01-07 (주)이뮤노텍 유기산, ｌ―카르니틴, ｌ―아르기닌 및 니코틴아미드를 유효성분으로 포함하는 비만의 예방 및 개선용 조성물
EP2716167A1 (en) * 2012-10-02 2014-04-09 Lunamed AG Non-pharmaceutical composition comprising short chain fatty acids
KR20160066253A (ko) * 2014-12-02 2016-06-10 (주)아모레퍼시픽 이카리시드 b2를 함유하는 대사 증후군 예방 또는 개선용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63280027A (ja) 1987-05-11 1988-11-17 Nichinichi Shokuhin Kk 抗高脂血症剤
US6787348B1 (en) * 1998-08-26 2004-09-07 Chr. Hansen Liquid starter cultures having improved storage stability and use thereof
WO2005077390A1 (ja) 2004-02-16 2005-08-25 Yasuo Kawai 血糖値低下剤、糖尿病治療・予防剤及びその製造方法
JP5569710B2 (ja) 2009-02-27 2014-08-13 国立大学法人広島大学 肥満予防又は改善剤
KR101508586B1 (ko) * 2013-10-21 2015-04-08 한국식품연구원 비만억제능이 우수한 신규한 엔테로코커스 휘칼리스 md366 균주
KR101611829B1 (ko) * 2015-06-08 2016-04-14 주식회사 쎌바이오텍 비만 및 비만으로 야기된 대사성 질환의 예방 또는 치료를 위한 페디오코커스 펜토사세우스 cbt sl4 균주 및 이를 포함하는 조성물
JP6782302B2 (ja) 2016-09-06 2020-11-11 ビージーアイ シェンチェン クリステンセネラ菌（Ｃｈｒｉｓｔｅｎｓｅｎｅｌｌａ ｉｎｔｅｓｔｉｎｉｈｏｍｉｎｉｓ）およびその使用
EP3511406A4 (en) 2016-09-06 2020-04-01 BGI Shenzhen FAECALIBACTERIUM LONGUM AND APPLICATION THEREOF

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002530326A (ja) * 1998-11-25 2002-09-17 ヨマー、ファルマカ、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング 感染症の治療のためのホスホノ蟻酸誘導体の使用
JP2002080357A (ja) * 2000-09-05 2002-03-19 Kao Corp 高血圧症予防・改善・治療剤
KR20130001744A (ko) * 2011-06-24 2013-01-07 (주)이뮤노텍 유기산, ｌ―카르니틴, ｌ―아르기닌 및 니코틴아미드를 유효성분으로 포함하는 비만의 예방 및 개선용 조성물
EP2716167A1 (en) * 2012-10-02 2014-04-09 Lunamed AG Non-pharmaceutical composition comprising short chain fatty acids
KR20160066253A (ko) * 2014-12-02 2016-06-10 (주)아모레퍼시픽 이카리시드 b2를 함유하는 대사 증후군 예방 또는 개선용 조성물

Also Published As

Publication number Publication date
JP2019535828A (ja) 2019-12-12
US20210315946A1 (en) 2021-10-14
WO2018093238A2 (ko) 2018-05-24
KR20180056972A (ko) 2018-05-30
JP7012736B2 (ja) 2022-02-14
KR101912774B1 (ko) 2018-10-29
US11564955B2 (en) 2023-01-31

Similar Documents

Publication Publication Date Title
WO2018093238A3 (ko) 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
WO2012088519A8 (en) Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders
MY197024A (en) Amylin analogues
WO2016190683A8 (ko) 길경 추출물을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
UA122342C2 (uk) Спосіб інгібування всмоктування та/або прискорення виведення ліпідів за допомогою d-псикози
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
RU2015129066A (ru) Применение bifidobacterium animalis для лечения или предотвращения набора веса и инсулинорезистентности
WO2016190682A3 (ko) 모루신, 구와논 지 또는 상백피를 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
HK1216506A1 (zh) 含硒組合物及其治療和預防與線粒體功能障礙有關的疾病或病症的應用
EP4219714A3 (en) Rna interference mediated inhibition of tmprss6
WO2018169282A3 (ko) Atpif1을 함유하는 당뇨 치료용 약학조성물
WO2015095354A3 (en) Compositions and methods for treating fatty tissue buildup
MY177974A (en) A pharmaceutical composition for prevention of diet induced obesity
IN2014DN08240A (ko)
NZ754706A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
WO2018093237A3 (ko) 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
EP4470625A3 (en) A pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting
WO2011126342A3 (ko) 대잎둥굴레 또는 층층갈고리둥굴레 추출물의 신규한 용도
WO2016190566A3 (ko) 아위버섯 물 추출물을 유효성분으로 함유하는 대사성질환의 예방 및 치료용 약학적 조성물 또는 건강기능성식품
EP2801356A3 (en) DHA and EPA for the reduction of oxidative stress
WO2011118957A3 (ko) 파프리카 추출물을 함유하는 염증, 알레르기 또는 천식 질환 치료용 조성물
WO2018078599A3 (en) Composition for the preventive or curative treatment of liver disorders
WO2013085338A3 (ko) 수련뿌리 추출물, 이의 분획물 또는 이로부터 분리된 폴리페놀계 화합물을 유효성분으로 함유하는 대사성 질환 예방 및 치료용 약학적 조성물
WO2016008642A3 (en) Compositions comprising cinnamaldehyde and zinc and methods of using such compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17871255

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2019547566

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17871255

Country of ref document: EP

Kind code of ref document: A2